Home › Funds › Parkman Healthcare Partners LLC › EWTX

Parkman Healthcare Partners LLC position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Parkman Healthcare Partners LLC reported holding 327,954 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 1.20% of its reported portfolio and ranking #32 among its reported holdings. Parkman Healthcare Partners LLC has disclosed EWTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)327.95K sh
Reported value held$13.31M
Portfolio Weight1.20%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Parkman Healthcare Partners LLC's EWTX position evolved

Parkman Healthcare Partners LLC first disclosed a stake in EWTX in Q3 2023 at 473,312 shares (US$2.7M). The position peaked in Q2 2026 at 577,036 shares, worth US$23.4M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 327,954 shares valued at US$13.3M — a reduction of -249,082 shares quarter over quarter.. Notable position changes include a 52% increase in Q2 2025 (shares rose 24% over the following quarter), a 79% increase in Q2 2026 (shares were roughly flat over the following quarter), a 43% trim in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 473.31K $2.71M New
Q4 2023 651.62K $7.13M Add
Q1 2024 653.65K $11.92M Hold
Q2 2024 574.52K $10.35M Reduce
Q3 2024 657.07K $17.54M Add
Q4 2024 381.17K $10.18M Reduce
Q1 2025 425.41K $9.36M Add
Q2 2025 647.33K $8.49M Add
Q3 2025 550.17K $8.92M Reduce
Q4 2025 427.69K $10.61M Reduce
Q1 2026 322.83K $10.17M Reduce
Q2 2026 577.04K $23.44M Add
Q3 2026 327.95K $13.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Parkman Healthcare Partners LLC held EWTX?

Parkman Healthcare Partners LLC has disclosed EWTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Parkman Healthcare Partners LLC's current position in EWTX?

As of Q3 2026, Parkman Healthcare Partners LLC holds 327.95K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $13.31M, representing 1.20% of its reported portfolio and ranking #32.

Has Parkman Healthcare Partners LLC been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in EWTX. The position peaked in Q2 2026 at 577.04K shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.